3004.90.92.39 - Other 🖩

This HTS classification, 3004.90.92.39, designates "Other" medicaments primarily affecting the central nervous system, specifically within the subcategory of antidepressants, tranquilizers, and other psychotherapeutic agents, that are not otherwise specified. These are therapeutic or prophylactic preparations in measured doses or retail packaging, excluding those explicitly classified under headings 3002, 3005, or 3006. The "Other" designation signifies that the medicament's active pharmaceutical ingredient does not fall under the specific entries for lorazepam (3004.90.92.37) or olanzapine (3004.90.92.38), nor any other more granularly defined psychotherapeutic agents.

The key differentiator for this residual category lies in the absence of a specific chemical entity that warrants a more detailed HTS code. Classification here relies on the medicament being a recognized psychotherapeutic agent that primarily acts on the central nervous system but is not specifically listed among its sibling entries. Importers and exporters must ensure that the product's intended therapeutic use and its primary pharmacological action on the CNS are confirmed, and that its active ingredient is not covered by any more specific HTS subheadings at this level or higher.

As a leaf node, this category does not have further subdivisions. Therefore, to accurately classify goods under 3004.90.92.39, one must confirm that the medicament meets the general requirements of heading 3004, specifically the "medicaments" category, is for therapeutic or prophylactic use, is presented in measured doses or retail packaging, primarily affects the central nervous system as an antidepressant, tranquilizer, or psychotherapeutic agent, and is not enumerated under any more specific preceding HTS codes.